GACP accredited, licensed cultivator of medical cannabis based in the EU

EU-based company with cultivation in Portugal and licensed distribution entity in Germany looking to expand the production capacity of high-quality, non-irradiated cannabis products

• Wholly-owned, standalone, innovative ~1,500 sq. m. indoor cultivation facility sitting on 2,9 hectares of land in Portugal
• Facility is comprised of multiple cultivation rooms, vegetation rooms and mother rooms
• Phase 2 is pending completion and consists of sufficient space to construct a 3,000 sq.m high-tech indoor cultivation facility and 3,000 sq.m. GMP certified facility for processing + extraction
• Currently operational and undertaking cultivation and B-2-B sales activities across the cannabis value chain
• GACP accreditation facilitates high quality cannabis cultivation and export
• Completed 3 cultivation cycles of high THC (25%+) genetics to date
• Production capability of 4 tons of cannabis flower and up to 150k bottles of extracts per year
• Projecting ~€7.6 million  of sales revenue with combined cultivation and extraction activity plans in 2023
• The company has a distribution hub in Germany, that possesses the needed licensing to distribute cannabis products directly to pharmacies
• Cultivated cannabis flowers do not need irradiation, which allows buyers to quickly introduce and sell the product to the market avoiding the process of attaining the AMRAdV
• Pending supply agreement for distributing product to the German market and further supply agreements in discussion
• Looking for a strategic partner to provide equity financing to support the build out of a custom-designed 6,000 sq. m. cultivation and EU-GMP processing facility

Seeking €12.5 million financing to build out a custom-designed 6,000 sq. m. cultivation and EU-GMP processing facility

https://www.hydeadvisory.com/listing/8305410929